This crucial role of p53 in the elimination of damaged cells is underlined by the clinical evidence that UVR-induced p53 mutations are highly frequent in human SCC and BCC [46], with enrichment for C > T and CC > TT transitions at dipyrimidine sites. The gene discussed is TP53; the disease is skin basal cell carcinoma.